The Global Laser BPH Devices Market size is expected to reach $619.9 Million by 2028, rising at a market growth of 5.3% CAGR during the forecast period.
Benign prostate hyperplasia (BPH), usually known as enlargement of the prostate gland, is a general ailment that affects men with their increasing age. The enlarged prostate glands bring uncomfortable urinary symptoms, which include a blocked urine flow from the bladder. It may also cause problems with the bladder, urinary system, or kidneys. The intensity of the symptoms differs in people with enlarged prostate glands, and they are known to get worse with time.
The general indications and symptoms of BPH are the issues like urgent and frequent urination, inability to empty the bladder, difficulty in urinating, urine dribbling even after completion, and weak urine flow or stream. Usually, the prostate size is of a walnut or golf in adult men, and it can grow in size with time. As the gland gets bigger, it can squeeze the urethra, and the bladder wall becomes thicker.
With time, the bladder may weaken and lose the ability to get full or empty, which then causes the urine to remain in the bladder. Such problems may cause many of BPH's lower urinary tract symptoms (LUTS). Immediate attention is needed if the patient is not able to pass urine at all, which is called retention, or if they have renal failure. BPH is benign, meaning they are not cancer, nor do they lead to cancer. Still, cancer and BPH can happen at the same time.
BPH may not need any treatment, but if it starts to show symptoms, treatment may help. BPH is a common disease that affects about half of all men between the ages of 51 and 60. Some of the significant symptoms of BPH include; feeling the bladder is full even after passing urine. The urgency to pass urine often or every one to two hours. The need to start and stop many times while urinating. A weak urine streams. Also, if BPH becomes severe, one might not be able to pass urine at all, which is an emergency and must be treated immediately.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, OmniGuide, Inc., Richard Wolf GmbH, Coloplast Group, Agiliti, Inc., HealthTronics, Inc. (Altaris Capital Partners, LLC), Endo International PLC, Teleflex, Inc., Biolitec AG, and Metrum Cryoflex Sp. z o.o.
Benign prostate hyperplasia (BPH), usually known as enlargement of the prostate gland, is a general ailment that affects men with their increasing age. The enlarged prostate glands bring uncomfortable urinary symptoms, which include a blocked urine flow from the bladder. It may also cause problems with the bladder, urinary system, or kidneys. The intensity of the symptoms differs in people with enlarged prostate glands, and they are known to get worse with time.
The general indications and symptoms of BPH are the issues like urgent and frequent urination, inability to empty the bladder, difficulty in urinating, urine dribbling even after completion, and weak urine flow or stream. Usually, the prostate size is of a walnut or golf in adult men, and it can grow in size with time. As the gland gets bigger, it can squeeze the urethra, and the bladder wall becomes thicker.
With time, the bladder may weaken and lose the ability to get full or empty, which then causes the urine to remain in the bladder. Such problems may cause many of BPH's lower urinary tract symptoms (LUTS). Immediate attention is needed if the patient is not able to pass urine at all, which is called retention, or if they have renal failure. BPH is benign, meaning they are not cancer, nor do they lead to cancer. Still, cancer and BPH can happen at the same time.
BPH may not need any treatment, but if it starts to show symptoms, treatment may help. BPH is a common disease that affects about half of all men between the ages of 51 and 60. Some of the significant symptoms of BPH include; feeling the bladder is full even after passing urine. The urgency to pass urine often or every one to two hours. The need to start and stop many times while urinating. A weak urine streams. Also, if BPH becomes severe, one might not be able to pass urine at all, which is an emergency and must be treated immediately.
COVID-19 Impact Analysis
COVID-19 is expected to have a negative impact on laser benign prostatic hyperplasia (BPH) devices as a considerable number of hospitals, and clinics were restructured to increase their capacity for patients diagnosed with COVID-19. Non-essential procedures like laser BPH surgery were postponed or canceled due to the rapid rise in cases. The transportation and manufacturing of medical devices and other products were disrupted due to the lockdowns. The limited medical care and the increased burden of COVID-19-related hospitalization were factors responsible for the negative impact on the laser BPH devices market growth.Market Growth Factors
Benefits associated with laser treatment of the BPH
Patients can cut costs on hospital stays as these surgeries can be performed in a single day and don't require patients to spend much time in medical care. Patients' recovery with laser surgery is relatively fast compared to traditional surgeries. Also, with laser surgery, a catheter (a tube used to drain urine from the bladder after surgery) is usually required for less than 24 hours. Hence, the benefits of the laser treatment of BPH are expected to attract more patients to opt for this surgery and thereby surge the market for laser BPH devices in the forecasted period.The rise number of people with obesity
Men with obesity, especially those with high amounts of abdominal fat, are more prone to BPH. This is because obesity causes various mechanisms, including increased intra-abdominal pressure, oxidative stress, and a rise in the inflammation process, which are all favorable for BPH development. Also, the increased sympathetic nervous activity in central obesity is known to increase the development of BPH and the intensity of obstructive urinary symptoms. Thus, the rising cases of obesity globally will increase the number of people with BPH and the usage of laser BPH devices, boosting the market growth.Market Restraining Factor
Risks associated with the laser surgery of BPH
Some patient requires a follow-up treatment after the laser vaporization surgery as not all of the tissues are removed, and in some cases, it grows back with time. Urinary incontinence, or the inability to control the flow of urine, is an expected problem in all patients right after the surgery. Which requires them to wear pads for the first few days or weeks. The urge incontinence can be mild or severe depending on age, symptoms, prostate size, and other medical conditions. The issues related to laser treatment are expected to hamper the growth of the laser BPH devices market.Type Outlook
On the basis of type, the laser BPH devices market is divided into holmium laser, thulium laser, green light laser and others. The holmium laser segment dominated the laser BPH devices market with maximum revenue share in 2021. This is due to the rising number of product approvals and launches for the holmium laser. This procedure utilizes a laser to remove the tissue blocking the prostate's urine flow. Also, there is an increase in the number of companies manufacturing laser BPH devices. The increasing product approvals and the rising number of laser BPH manufacturing companies, will surge the segment's growth.
Procedure Outlook
By procedure, the laser BPH devices market is classified into photoselective vaporization of prostate and holmium laser ablation. The holmium laser ablation segment procured a substantial revenue share in the laser BPH devices market in 2021. This is because of the rising prevalence of benign prostate hyperplasia. The holmium laser conjunction can be utilized with a normal saline irrigant, eliminating the risk of dilutional hyponatremia. Also, the hemostatic properties of the holmium laser result in superior hemostasis, thus minimizing the risk of bleeding. These features of the holmium laser ablation of the prostate are expected to boost the segment’s growth.End user Outlook
Based on the end user, the laser BPH devices market is bifurcated into hospitals, clinics and others. The hospitals segment registered the highest revenue share in the laser BPH devices market in 2021. This is because of the rising expenditure by the governments to develop healthcare infrastructure and increase the number of hospitals. Also, hospitals have much larger space and more professional employees with well-equipped operating rooms and high-tech devices to ensure proper treatment. Hence, the benefits associated with the hospitals will surge the segment’ growth in the forecasted period.Regional Outlook
Region-wise, the laser BPH devices market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region generated the highest revenue share in the laser BPH devices market in 2021. This is due to the increasing number of populations suffering from benign prostatic hyperplasia. A growing number of benign prostatic hyperplasia industries are also manufacturing laser BPH devices. Also, there is a rising number of people with obesity in the region, further surging the cases of BPH. Hence, these factors are expected to surge the market growth in the region during the projected period.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, OmniGuide, Inc., Richard Wolf GmbH, Coloplast Group, Agiliti, Inc., HealthTronics, Inc. (Altaris Capital Partners, LLC), Endo International PLC, Teleflex, Inc., Biolitec AG, and Metrum Cryoflex Sp. z o.o.
Scope of the Study
By End-user
- Hospitals
- Clinics
- Others
By Procedure
- Photoselective Vaporization of Prostate
- Holium Laser Ablation
By Type
- Holmium Laser
- Thulium Laser
- Green Light Laser
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- OmniGuide, Inc.
- Richard Wolf GmbH
- Coloplast Group
- Agiliti, Inc.
- HealthTronics, Inc. (Altaris Capital Partners, LLC)
- Endo International PLC
- Teleflex, Inc.
- Biolitec AG
- Metrum Cryoflex Sp. z o.o.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Laser BPH Devices Market, by End User
1.4.2 Global Laser BPH Devices Market, by Procedure
1.4.3 Global Laser BPH Devices Market, by Type
1.4.4 Global Laser BPH Devices Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Laser BPH Devices Market by End User
3.1 Global Hospitals Market by Region
3.2 Global Clinics Market by Region
3.3 Global Others Market by Region
Chapter 4. Global Laser BPH Devices Market by Procedure
4.1 Global Photoselective Vaporization of Prostate Market by Region
4.2 Global Holium Laser Ablation Market by Region
Chapter 5. Global Laser BPH Devices Market by Type
5.1 Global Holmium Laser Market by Region
5.2 Global Thulium Laser Market by Region
5.3 Global Green Light Laser Market by Region
5.4 Global Others Market by Region
Chapter 6. Global Laser BPH Devices Market by Region
6.1 North America Laser BPH Devices Market
6.1.1 North America Laser BPH Devices Market by End User
6.1.1.1 North America Hospitals Market by Country
6.1.1.2 North America Clinics Market by Country
6.1.1.3 North America Others Market by Country
6.1.2 North America Laser BPH Devices Market by Procedure
6.1.2.1 North America Photoselective Vaporization of Prostate Market by Country
6.1.2.2 North America Holium Laser Ablation Market by Country
6.1.3 North America Laser BPH Devices Market by Type
6.1.3.1 North America Holmium Laser Market by Country
6.1.3.2 North America Thulium Laser Market by Country
6.1.3.3 North America Green Light Laser Market by Country
6.1.3.4 North America Others Market by Country
6.1.4 North America Laser BPH Devices Market by Country
6.1.4.1 US Laser BPH Devices Market
6.1.4.1.1 US Laser BPH Devices Market by End User
6.1.4.1.2 US Laser BPH Devices Market by Procedure
6.1.4.1.3 US Laser BPH Devices Market by Type
6.1.4.2 Canada Laser BPH Devices Market
6.1.4.2.1 Canada Laser BPH Devices Market by End User
6.1.4.2.2 Canada Laser BPH Devices Market by Procedure
6.1.4.2.3 Canada Laser BPH Devices Market by Type
6.1.4.3 Mexico Laser BPH Devices Market
6.1.4.3.1 Mexico Laser BPH Devices Market by End User
6.1.4.3.2 Mexico Laser BPH Devices Market by Procedure
6.1.4.3.3 Mexico Laser BPH Devices Market by Type
6.1.4.4 Rest of North America Laser BPH Devices Market
6.1.4.4.1 Rest of North America Laser BPH Devices Market by End User
6.1.4.4.2 Rest of North America Laser BPH Devices Market by Procedure
6.1.4.4.3 Rest of North America Laser BPH Devices Market by Type
6.2 Europe Laser BPH Devices Market
6.2.1 Europe Laser BPH Devices Market by End User
6.2.1.1 Europe Hospitals Market by Country
6.2.1.2 Europe Clinics Market by Country
6.2.1.3 Europe Others Market by Country
6.2.2 Europe Laser BPH Devices Market by Procedure
6.2.2.1 Europe Photoselective Vaporization of Prostate Market by Country
6.2.2.2 Europe Holium Laser Ablation Market by Country
6.2.3 Europe Laser BPH Devices Market by Type
6.2.3.1 Europe Holmium Laser Market by Country
6.2.3.2 Europe Thulium Laser Market by Country
6.2.3.3 Europe Green Light Laser Market by Country
6.2.3.4 Europe Others Market by Country
6.2.4 Europe Laser BPH Devices Market by Country
6.2.4.1 Germany Laser BPH Devices Market
6.2.4.1.1 Germany Laser BPH Devices Market by End User
6.2.4.1.2 Germany Laser BPH Devices Market by Procedure
6.2.4.1.3 Germany Laser BPH Devices Market by Type
6.2.4.2 UK Laser BPH Devices Market
6.2.4.2.1 UK Laser BPH Devices Market by End User
6.2.4.2.2 UK Laser BPH Devices Market by Procedure
6.2.4.2.3 UK Laser BPH Devices Market by Type
6.2.4.3 France Laser BPH Devices Market
6.2.4.3.1 France Laser BPH Devices Market by End User
6.2.4.3.2 France Laser BPH Devices Market by Procedure
6.2.4.3.3 France Laser BPH Devices Market by Type
6.2.4.4 Russia Laser BPH Devices Market
6.2.4.4.1 Russia Laser BPH Devices Market by End User
6.2.4.4.2 Russia Laser BPH Devices Market by Procedure
6.2.4.4.3 Russia Laser BPH Devices Market by Type
6.2.4.5 Spain Laser BPH Devices Market
6.2.4.5.1 Spain Laser BPH Devices Market by End User
6.2.4.5.2 Spain Laser BPH Devices Market by Procedure
6.2.4.5.3 Spain Laser BPH Devices Market by Type
6.2.4.6 Italy Laser BPH Devices Market
6.2.4.6.1 Italy Laser BPH Devices Market by End User
6.2.4.6.2 Italy Laser BPH Devices Market by Procedure
6.2.4.6.3 Italy Laser BPH Devices Market by Type
6.2.4.7 Rest of Europe Laser BPH Devices Market
6.2.4.7.1 Rest of Europe Laser BPH Devices Market by End User
6.2.4.7.2 Rest of Europe Laser BPH Devices Market by Procedure
6.2.4.7.3 Rest of Europe Laser BPH Devices Market by Type
6.3 Asia Pacific Laser BPH Devices Market
6.3.1 Asia Pacific Laser BPH Devices Market by End User
6.3.1.1 Asia Pacific Hospitals Market by Country
6.3.1.2 Asia Pacific Clinics Market by Country
6.3.1.3 Asia Pacific Others Market by Country
6.3.2 Asia Pacific Laser BPH Devices Market by Procedure
6.3.2.1 Asia Pacific Photoselective Vaporization of Prostate Market by Country
6.3.2.2 Asia Pacific Holium Laser Ablation Market by Country
6.3.3 Asia Pacific Laser BPH Devices Market by Type
6.3.3.1 Asia Pacific Holmium Laser Market by Country
6.3.3.2 Asia Pacific Thulium Laser Market by Country
6.3.3.3 Asia Pacific Green Light Laser Market by Country
6.3.3.4 Asia Pacific Others Market by Country
6.3.4 Asia Pacific Laser BPH Devices Market by Country
6.3.4.1 China Laser BPH Devices Market
6.3.4.1.1 China Laser BPH Devices Market by End User
6.3.4.1.2 China Laser BPH Devices Market by Procedure
6.3.4.1.3 China Laser BPH Devices Market by Type
6.3.4.2 Japan Laser BPH Devices Market
6.3.4.2.1 Japan Laser BPH Devices Market by End User
6.3.4.2.2 Japan Laser BPH Devices Market by Procedure
6.3.4.2.3 Japan Laser BPH Devices Market by Type
6.3.4.3 India Laser BPH Devices Market
6.3.4.3.1 India Laser BPH Devices Market by End User
6.3.4.3.2 India Laser BPH Devices Market by Procedure
6.3.4.3.3 India Laser BPH Devices Market by Type
6.3.4.4 South Korea Laser BPH Devices Market
6.3.4.4.1 South Korea Laser BPH Devices Market by End User
6.3.4.4.2 South Korea Laser BPH Devices Market by Procedure
6.3.4.4.3 South Korea Laser BPH Devices Market by Type
6.3.4.5 Singapore Laser BPH Devices Market
6.3.4.5.1 Singapore Laser BPH Devices Market by End User
6.3.4.5.2 Singapore Laser BPH Devices Market by Procedure
6.3.4.5.3 Singapore Laser BPH Devices Market by Type
6.3.4.6 Malaysia Laser BPH Devices Market
6.3.4.6.1 Malaysia Laser BPH Devices Market by End User
6.3.4.6.2 Malaysia Laser BPH Devices Market by Procedure
6.3.4.6.3 Malaysia Laser BPH Devices Market by Type
6.3.4.7 Rest of Asia Pacific Laser BPH Devices Market
6.3.4.7.1 Rest of Asia Pacific Laser BPH Devices Market by End User
6.3.4.7.2 Rest of Asia Pacific Laser BPH Devices Market by Procedure
6.3.4.7.3 Rest of Asia Pacific Laser BPH Devices Market by Type
6.4 LAMEA Laser BPH Devices Market
6.4.1 LAMEA Laser BPH Devices Market by End User
6.4.1.1 LAMEA Hospitals Market by Country
6.4.1.2 LAMEA Clinics Market by Country
6.4.1.3 LAMEA Others Market by Country
6.4.2 LAMEA Laser BPH Devices Market by Procedure
6.4.2.1 LAMEA Photoselective Vaporization of Prostate Market by Country
6.4.2.2 LAMEA Holium Laser Ablation Market by Country
6.4.3 LAMEA Laser BPH Devices Market by Type
6.4.3.1 LAMEA Holmium Laser Market by Country
6.4.3.2 LAMEA Thulium Laser Market by Country
6.4.3.3 LAMEA Green Light Laser Market by Country
6.4.3.4 LAMEA Others Market by Country
6.4.4 LAMEA Laser BPH Devices Market by Country
6.4.4.1 Brazil Laser BPH Devices Market
6.4.4.1.1 Brazil Laser BPH Devices Market by End User
6.4.4.1.2 Brazil Laser BPH Devices Market by Procedure
6.4.4.1.3 Brazil Laser BPH Devices Market by Type
6.4.4.2 Argentina Laser BPH Devices Market
6.4.4.2.1 Argentina Laser BPH Devices Market by End User
6.4.4.2.2 Argentina Laser BPH Devices Market by Procedure
6.4.4.2.3 Argentina Laser BPH Devices Market by Type
6.4.4.3 UAE Laser BPH Devices Market
6.4.4.3.1 UAE Laser BPH Devices Market by End User
6.4.4.3.2 UAE Laser BPH Devices Market by Procedure
6.4.4.3.3 UAE Laser BPH Devices Market by Type
6.4.4.4 Saudi Arabia Laser BPH Devices Market
6.4.4.4.1 Saudi Arabia Laser BPH Devices Market by End User
6.4.4.4.2 Saudi Arabia Laser BPH Devices Market by Procedure
6.4.4.4.3 Saudi Arabia Laser BPH Devices Market by Type
6.4.4.5 South Africa Laser BPH Devices Market
6.4.4.5.1 South Africa Laser BPH Devices Market by End User
6.4.4.5.2 South Africa Laser BPH Devices Market by Procedure
6.4.4.5.3 South Africa Laser BPH Devices Market by Type
6.4.4.6 Nigeria Laser BPH Devices Market
6.4.4.6.1 Nigeria Laser BPH Devices Market by End User
6.4.4.6.2 Nigeria Laser BPH Devices Market by Procedure
6.4.4.6.3 Nigeria Laser BPH Devices Market by Type
6.4.4.7 Rest of LAMEA Laser BPH Devices Market
6.4.4.7.1 Rest of LAMEA Laser BPH Devices Market by End User
6.4.4.7.2 Rest of LAMEA Laser BPH Devices Market by Procedure
6.4.4.7.3 Rest of LAMEA Laser BPH Devices Market by Type
Chapter 7. Company Profiles
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisition and Mergers:
7.2 Coloplast Group
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Endo International PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expense
7.4 Teleflex, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Geographical Expansions:
7.5 OmniGuide, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Trials and Approvals:
7.5.2.2 Acquisition and Mergers:
7.6 Biolitec AG
7.6.1 Company Overview
7.7 Metrum Cryoflex Sp. z o.o.
7.7.1 Company Overview
7.8 HealthTronics, Inc. (Altaris Capital Partners, LLC)
7.8.1 Company Overview
7.9 Agiliti, Inc.
7.9.1 Company Overview
7.10. Richard Wolf GmbH
7.10.1 Company Overview
Companies Mentioned
- Boston Scientific Corporation
- OmniGuide, Inc.
- Richard Wolf GmbH
- Coloplast Group
- Agiliti, Inc.
- HealthTronics, Inc. (Altaris Capital Partners, LLC)
- Endo International PLC
- Teleflex, Inc.
- Biolitec AG
- Metrum Cryoflex Sp. z o.o.
Methodology
LOADING...
